Vdac1 — Voltage Dependent Anion Channel 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VDAC1 (Voltage Dependent Anion Channel 1) is a gene located on chromosome 5q31 that encodes a voltage-dependent anion channel protein found in the outer mitochondrial membrane. VDAC1 is a crucial component of the mitochondrial permeability transition pore (mPTP) and regulates metabolite exchange between the cytosol and mitochondria.
VDAC1 is a 31 kDa β-barrel protein that forms voltage-gated channels in the mitochondrial outer membrane:
- β-barrel structure: Composed of 19 β-strands forming a hollow pore
- N-terminal α-helix: Located inside the channel, involved in gating
- Voltage sensor: Positive charges on the N-terminal domain respond to membrane potential
- NADH binding site: Located in the N-terminal region
- ATP binding site: C-terminal region interacts with nucleotides
The channel adopts a solenoid-like fold with the β-strands arranged in a closed barrel, creating a water-filled pore. The N-terminal helix blocks the pore in the closed state.
VDAC1 encodes the voltage-dependent anion channel 1, also known as porin. This protein forms large, voltage-gated channels in the outer mitochondrial membrane that allow the passage of small molecules (<5 kDa) including ATP, ADP, ions, and metabolites.
- ATP/ADP exchange: VDAC1 allows ATP produced in mitochondria to exit to the cytosol while permitting ADP to enter
- Calcium handling: Regulates mitochondrial Ca²⁺ uptake and release
- Metabolite flux: Permits passage of Krebs cycle intermediates, nucleotides, and ions
- ROS signaling: Modulates release of reactive oxygen species
VDAC1 plays a central role in apoptosis:
- mPTP component: VDAC1 is a key component of the mitochondrial permeability transition pore
- Cytochrome c release: VDAC1 oligomerization facilitates cytochrome c release
- Pro-apoptotic interactions: Interacts with pro-apoptotic proteins (Bax, Bak, tBid)
- Anti-apoptotic effects: VDAC1-hexamer interactions with Bcl-2 family proteins
- Metabolic coupling: Couples cytosolic and mitochondrial metabolism
- Creatine kinase shuttle: Works with mitochondrial creatine kinase
- Hexokinase binding: Interaction with hexokinase enhances glycolysis
VDAC1 is ubiquitously expressed, with high levels in brain, heart, liver, and kidney. In the brain, it is expressed in neurons and glia throughout the cortex, hippocampus, basal ganglia, and cerebellum. Astrocytes and microglia also express VDAC1, with elevated levels in reactive states.
VDAC1 is critically involved in PD pathophysiology:
- Mitochondrial dysfunction: VDAC1 dysfunction contributes to mitochondrial defects in dopaminergic neurons
- Complex I deficiency: VDAC1 interacts with damaged complex I subunits
- α-Synuclein interactions: α-Synuclein oligomers can bind to VDAC1, forming abnormal channels
- Apoptosis: Enhanced VDAC1-mediated cytochrome c release in PD neurons
- Therapeutic target: VDAC1 modulators are being explored for PD treatment
VDAC1 involvement in AD:
- Amyloid-β effects: Aβ interacts with VDAC1, altering channel function
- Mitochondrial dysfunction: VDAC1 contributes to mitochondrial bioenergetic deficits
- Calcium dysregulation: Altered mitochondrial Ca²⁺ handling through VDAC1
- Energy failure: Reduced ATP export via VDAC1 in neurons
- Apoptosis: Enhanced VDAC1 oligomerization and cytochrome c release
VDAC1 in ALS:
- Mitochondrial dysfunction: Central to motor neuron mitochondrial defects
- Mutant SOD1: Mutant SOD1 can interact with VDAC1, disrupting function
- Energy crisis: Impaired ATP production and export
- Apoptotic pathways: VDAC1-mediated apoptosis contributes to motor neuron loss
VDAC1 involvement in HD:
- Mutant huntingtin: Interacts with VDAC1, impairing channel function
- Energy deficit: Reduced mitochondrial ATP export
- Calcium dysregulation: Altered mitochondrial calcium handling
- Apoptosis: Enhanced VDAC1-dependent cell death
VDAC1 is modified by:
- Phosphorylation: Multiple serine/threonine phosphorylation sites (PKA, PKC)
- Oxidation: ROS can oxidize VDAC1 cysteine residues
- Nitrosylation: S-nitrosylation affects channel function
- Acetylation: Lysine acetylation modulates interactions
VDAC1 interacts with multiple proteins:
- Metabolic enzymes: Hexokinase, creatine kinase, glyceraldehyde-3-phosphate dehydrogenase
- Bcl-2 family: Bcl-2, Bcl-xL (anti-apoptotic), Bax, Bak (pro-apoptotic)
- Cytoskeletal proteins: Tubulin, actin
- Ion channels: mitochondrial calcium uniporter (MCU)
- Proteins: Hsp90, PARK2 (Parkin)
Targeting VDAC1:
- VDAC1 modulators: Small molecules that regulate VDAC1 activity
- Apoptosis inhibitors: Blocking VDAC1 oligomerization
- Metabolic enhancers: Improving mitochondrial function
- Neuroprotective agents: Targeting VDAC1-mediated pathways
VDAC1 as a biomarker:
- Blood-brain barrier dysfunction: VDAC1 in CSF indicates mitochondrial damage
- Disease progression: VDAC1 levels correlate with disease severity
- Therapeutic monitoring: Changes with treatment response
The study of Vdac1 — Voltage Dependent Anion Channel 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Shoshan-Barmatz et al., VDAC, the mitochondrial gatekeeper (2010)
- Rostovtseva & Bezrukov, VDAC regulation of mitochondrial bioenergetics (2012)
- Madesh & Hajnóczky, VDAC-dependent apoptosis (2001)
- Yu et al., VDAC in Parkinson's disease (2020)
- VDAC1 and Alzheimer's disease (2019)
- Thinnes, VDAC and neurodegeneration (2014)
- Giorgio et al., VDAC in cell death (2018)